News

Thursday, 17 November 2011 - 14:26

The North Gauteng High Court in Pretoria has ruled in favour of the Medicines Control Council (MCC) and others in a matter concerning Adcock Ingram’s resistance to the MCC’s decision to cancel the registration of drugs containing dextropropoxyphene (DPP). The MCC made the decision in April 2011 after coming to the conclusion that the risks posed by such medicines outweigh their benefits.

The North Gauteng High Court in Pretoria has ruled in favour of the Medicines Control Council (MCC) and others in a matter concerning Adcock Ingram’s resistance to the MCC’s decision to...

Read more
Thursday, 17 November 2011 - 13:57

A Joint Statement by Treatment Action Campaign, Treatment Action Group, HIV i-Base, European AIDS Treatment Group and SECTION27

17 November 2011

The exorbitant price of AIDS medicines, especially antiretrovirals, has been one of the main barriers to people with HIV accessing them, especially in developing countries. As activist organisations we have been at the forefront of many of the struggles to make medicines affordable.

A Joint Statement by Treatment Action Campaign, Treatment Action Group, HIV i-Base, European AIDS Treatment Group and SECTION27...

Read more
Wednesday, 16 November 2011 - 17:01

Press release
16 November 2011

(Cape Town) - Ten years ago this week, member countries of the World Trade Organisation (WTO) signed the Declaration on the TRIPS Agreement and Public Health (“the Doha Declaration”). Members were gathered in Doha to discuss valid concerns that an international agreement to protect intellectual property – the Agreement on Trade-related Aspects of Intellectual Property Rights (TRIPS)[1] - would undermine the ability of countries to achieve the right to health.

Press release
16 November...

Read more
Tuesday, 15 November 2011 - 10:25

Treatment Action Campaign Comment on Medicines Control Council and others v Adcock Ingram and another: urgent rescission application

Treatment Action Campaign Comment on Medicines Control Council and others v Adcock Ingram and another: urgent rescission application

Media Release 9 November, 2011

According to media reports today, the Medicines Control Council (MCC) instituted urgent proceedings to set aside a settlement agreement purportedly entered into with Adcock Ingram Ltd (“Adcock Ingram”). The settlement agreement relates to the deregistration of...

Read more
Monday, 31 October 2011 - 17:39

TAC supports voluntary medical male circumcision (VMMC) because of the clear evidence that it reduces a heterosexual man’s risk of contracting HIV. TAC’s previous briefings on VMMC explain this evidence in detail and remain largely correct. This briefing highlights the evidence that has emerged from follow up trials.

 
Recommendations
 
  • The evidence that voluntary medical male circumcision (VMMC) reduces the risk of HIV infection in heterosexual men is clear. Therefore the Department of Health must set ambitious targets for the...
Read more

Pages